1. Home
  2. ALLK vs FOSL Comparison

ALLK vs FOSL Comparison

Compare ALLK & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • FOSL
  • Stock Information
  • Founded
  • ALLK 2012
  • FOSL 1984
  • Country
  • ALLK United States
  • FOSL United States
  • Employees
  • ALLK N/A
  • FOSL N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • FOSL Consumer Specialties
  • Sector
  • ALLK Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • ALLK Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • ALLK 101.0M
  • FOSL 100.0M
  • IPO Year
  • ALLK 2018
  • FOSL 1993
  • Fundamental
  • Price
  • ALLK $0.86
  • FOSL $1.77
  • Analyst Decision
  • ALLK Hold
  • FOSL
  • Analyst Count
  • ALLK 4
  • FOSL 0
  • Target Price
  • ALLK $1.67
  • FOSL N/A
  • AVG Volume (30 Days)
  • ALLK 827.7K
  • FOSL 522.1K
  • Earning Date
  • ALLK 03-13-2025
  • FOSL 03-12-2025
  • Dividend Yield
  • ALLK N/A
  • FOSL N/A
  • EPS Growth
  • ALLK N/A
  • FOSL N/A
  • EPS
  • ALLK N/A
  • FOSL N/A
  • Revenue
  • ALLK N/A
  • FOSL $1,223,954,000.00
  • Revenue This Year
  • ALLK N/A
  • FOSL N/A
  • Revenue Next Year
  • ALLK N/A
  • FOSL N/A
  • P/E Ratio
  • ALLK N/A
  • FOSL N/A
  • Revenue Growth
  • ALLK N/A
  • FOSL N/A
  • 52 Week Low
  • ALLK $0.54
  • FOSL $0.75
  • 52 Week High
  • ALLK $1.69
  • FOSL $2.61
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 35.16
  • FOSL 50.19
  • Support Level
  • ALLK $0.81
  • FOSL $1.61
  • Resistance Level
  • ALLK $1.00
  • FOSL $1.97
  • Average True Range (ATR)
  • ALLK 0.13
  • FOSL 0.16
  • MACD
  • ALLK -0.03
  • FOSL -0.03
  • Stochastic Oscillator
  • ALLK 8.43
  • FOSL 38.10

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: